| Literature DB >> 35713443 |
Kazunori Hayashi1,2, Toru Tanaka1, Akira Sakawa1, Tsuneyuki Ebara1, Hidekazu Tanaka1, Hiroaki Nakamura2.
Abstract
ABSTRACT: Prospective case-control studyThis study aimed to investigate the effect of self-quarantine on the changes in low back symptoms and activities of daily living (ADL) due to low physical activity because of the COVID-19 pandemic in patients with lumbar spinal stenosis (LSS).The frequency and intensity of low back and leg pain have reportedly increased in healthy subjects because of self-quarantine.Patients with LSS who self-quarantined from baseline (SQ group) were matched to controls who did not self-quarantine (non-SQ group), based on age, sex, medication, ADL, and the numeric rating scale score for low back symptoms. The change in low back symptoms, ADL, and health-related quality of life between baseline and follow-up were compared between the groups.The SQ and non-SQ group included 80 and 60 patients, respectively. Compared with the baseline, the numeric rating scale score for low back pain at follow-up in the SQ group significantly improved (P = .004, median; 1 point), but not in the non-SQ group. No significant difference was found regarding changes in leg pain or numbness. Low back pain improvement did not lead to ADL improvement. The short form 12 evaluation revealed the role/social component score in the SQ group to be significantly lower than that in the non-SQ group; no difference was found for the physical or mental components at follow-up.Self-quarantine with conservative treatment effected short-term low back pain improvement in patients with LSS. However, no improvement in ADL was found. Self-quarantine had an unfavorable impact for health-related quality of life. The effect of self-quarantine can influence the treatment results of LSS.Entities:
Mesh:
Year: 2022 PMID: 35713443 PMCID: PMC9276399 DOI: 10.1097/MD.0000000000029388
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1Criteria for Determination of the Daily Life Independence Level (bedridden level) of the Elderly with Disability. ADL = activities of daily living.
Figure 2Flowchart outlining the inclusion and exclusion of participants. CT = computed tomography, MRI = magnetic resonance imaging, NRS = numeric rating scale, SQ = self-quarantine.
The detailed patient data at baseline.
| Factors | SQ group (n = 80) | non-SQ group (n = 60) |
|
| Demographics | |||
| Age (y) | 75.5 | 74.9 | .554 |
| BMI (kg/m2) | 24.9 | 24.0 | .337 |
| Follow-up period for LSS (months) | 71.9 | 63.9 | .532 |
| Period from baseline to follow-up (days) | 67.4 | 66.8 | .965 |
| Sex | |||
| Female | 45 | 28 | .261 |
| Male | 35 | 32 | |
| Additional diagnosis | |||
| None of the following | 52 | 40 | .837 |
| Degenerative spondylolisthesis | 19 | 15 | .864 |
| Foraminal stenosis | 6 | 2 | .466 |
| Lipomatosis | 2 | 2 | 1.000 |
| Spondylotic spondylolisthesis | 1 | 1 | 1.000 |
| Comorbidity | |||
| Yes | 69 | 44 | .081 |
| Hypertension | 49 | 24 | .016 |
| Diabetes | 21 | 13 | .568 |
| Asthma/pulmonary diseases | 5 | 7 | .244 |
| Cardiac/vascular diseases | 12 | 7 | .595 |
| Liver/kidney diseases | 7 | 2 | .301 |
| Osteoporosis required medication | 6 | 8 | .255 |
| Medication at baseline | |||
| Yes | 70 | 57 | .130 |
| Cold/hot patch | 49 | 35 | .727 |
| NSAIDs | 28 | 22 | .839 |
| Tramadol/Acetaminophen | 20 | 13 | .646 |
| Pregabalin/Mirogabalin | 29 | 31 | .068 |
| Prostaglandin | 16 | 14 | .634 |
| Mecobalamin | 13 | 7 | .443 |
| Any prescription change | 16 | 10 | .460 |
| The daily independence level at baseline | |||
| J1 | 55 | 43 | .641 |
| J2 | 21 | 15 | |
| A1 | 2 | 0 | |
| A2 | 0 | 0 | |
| not identified | 2 | 2 | |
| Numerical rating scale | |||
| Low back pain (median) | 4.2 (4.5) | 4.0 (4.5) | .771 |
| Leg pain | 3.3 (3) | 3.1 (3) | .748 |
| Leg numbness | 2.3 (1.5) | 2.4 (2) | .892 |
BMI = body mass index, LSS = lumbar spinal stenosis, NSAIDs = non-steroidal anti-inflammatory drugs.
Figure 3Box plot of the change in numeric rating scale score of the non-SQ group (white box) and the SQ group (grey box); (A) for low back pain, (B) leg pain, (C) and leg numbness. NRS = numeric rating scale.
Figure 4Box plot of the mental, physical, and role/social component summary scores of Short Form 12 (SF-12) at follow-up for the non-SQ group (white box) and the SQ group (grey box).
Comparison of demographic data and NRS scores for low back symptoms between patients who experienced an improvement in daily life independence level and those who did not.
| Factors | Patients with ADL improvement (n = 16) | ADL not improved (n = 20) |
|
| Self-quarantined | 10 | 12 | .878 |
| Demographics | |||
| Age (y) | 79 | 78.1 | .626 |
| BMI (kg/m2) | 24.5 | 26.4 | .290 |
| Sex | |||
| Female | 8 | 10 | 1.000 |
| Male | 8 | 10 | |
| NRS at baseline | |||
| Low back pain | 4.75 | 4.00 | .440 |
| Leg pain | 4.09 | 2.48 | .089 |
| Leg numbness | 2.44 | 2.10 | .718 |
| NRS improvement | |||
| Low back pain | 1.25 | 0.25 | .352 |
| Leg pain | 1.66 | 0.58 | .066 |
| Leg numbness | 0.12 | 0.05 | .683 |
ADL = activity of daily life, BMI = body mass index, NRS = numerical rating scale.